Singapore-based oncology startup AUM Biosciences has raised $1.5 million (S$2.04 million) in seed funding to develop affordable oncology medicines in Asia. The announcement was made in June this year.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
